Status:
COMPLETED
Transcutaneous Bilirubin Levels From Covered Skin
Lead Sponsor:
Ankara Training and Research Hospital
Conditions:
Hyperbilirubinemia, Neonatal
Eligibility:
All Genders
1-28 years
Brief Summary
The aim of this study was to evaluate the levels of total serum bilirubin and transcutaneous bilirubin in newborns, measured in both covered and exposed areas, before phototherapy, 24th hour of photot...
Detailed Description
Aim: This study aimed to evaluate total serum bilirubin and transcutaneous bilirubin levels measured from covered and exposed areas in newborns before phototherapy, after 24 hours of phototherapy, and...
Eligibility Criteria
Inclusion
- Aged 0-28 days, Diagnosis of indirect hyperbilirubinemia Parent/guardian consent was obtained.
Exclusion
- Direct hyperbilirubinemia, Major congenital anomaly, Severe sepsis, Circulatory disorder, Need for blood exchange, Rehospitalization
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06105879
Start Date
January 1 2022
End Date
June 1 2023
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Training and Research Hospital
Ankara, Turkey (Türkiye)